← Payloads & linkersCC[C@H](C)[C@@H](C(=O)N(COC(=O)CC(C)C)[C@H](C[C@H](C1=NC(=CS1)C(=O)N[C@@H](CC2=CC=C(C=C2)C)C[C@H](C)C(=O)O)OC(=O)C)C(C)C)NC(=O)[C@H]3CCCCN3C
Physicochemistry
Properties
Bioactivity
ADCdb payload page (PAY0PCTOE / PubChem CID 52945681, tubulysin) reports cytotoxicity IC50 2.2 nM (A2780 ovarian) and 2.5 nM (LNCaP prostate); mechanism is inhibition of tubulin polymerization into microtubules. Clinically, BMS-986148 MTD was 1.2 mg/kg IV q3w with ORR ~2-23% acro
1 agent
ADCs built on this payload
Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
BMS-986148MSLN